Insiders · Profile

Gupta Rishi

Director at Enliven Therapeutics. Filing since 16 May 2024. CIK 0001537370

Company

Date

Role

Action

Shares

Amount

Of holding

ELVN Enliven Therapeutics, Inc.

16 May 2024

Director

Sold at will

1,033,300

$22.88M

80.2%

1 decision on file.